MRT (TSE:6034) Stock Based Compensation: 円0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6034 MRT Inc TSE:6034
63 GF Score
Price 円630.00
GF Value 円623.08
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is MRT Stock Based Compensation?

MRT TSE:6034 63 Stock Based Compensation is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円623.08 (Fairly Valued). The stock has 4 warning signs investors should review.

MRT's Stock Based Compensation for the three months ended in Mar. 2026 was 円0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

MRT Stock Based Compensation Related Terms

MRT Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for MRT's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRT Stock Based Compensation Chart

MRT Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MRT Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:6034
63GF Score
MRT Inc TSE:6034
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MRT Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

What does a Stock Based Compensation of 円0 Mil mean?
MRT (TSE:6034) has a Stock Based Compensation of 円0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MRT and its competitors.
Is MRT's Stock Based Compensation too high?
MRT's current Stock Based Compensation is 円0 Mil. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's Stock Based Compensation compare to HCA and THC?
MRT's Stock Based Compensation of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MRT and its competitors. MRT's current Stock Based Compensation is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円623.08, compared to a current price of 円630.00 — trading 1.1% above its estimated fair value. The current Stock Based Compensation is 円0 Mil. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For MRT (TSE:6034), the current Stock Based Compensation is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MRT (TSE:6034) Overvalued in 2026?

Based on GuruFocus' analysis, MRT stock appears to be overvalued. The current stock price of 円630.00 is trading 1.1% above its estimated GF Value™ of 円623.08. GuruFocus considers MRT to be Fairly Valued.

Key valuation signals for TSE:6034:

  • Stock Based Compensation: 円0 Mil
  • GF Value™: 円623.08 vs. price of 円630.00 (1.1% above fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MRT Business Description

Address 1-18-2 Jinnan, 3rd Floor, Frame Jinnanzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score

Get the complete analysis for TSE:6034

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円630.00
Price
円623.08
GF Value